Once Daily Self-Monitoring of Blood Glucose (SMBG) Improves Glycemic Control in Oral Hypoglycemic Agents (OHA)–Treated Diabetes
نویسندگان
چکیده
منابع مشابه
Color record in self-monitoring of blood glucose improves glycemic control by better self-management.
BACKGROUND Color affects emotions, feelings, and behaviors. We hypothesized that color used in self-monitoring of blood glucose (SMBG) is helpful for patients to recognize and act on their glucose levels to improve glycemic control. Here, two color-indication methods, color record (CR) and color display (CD), were independently compared for their effects on glycemic control in less frequently i...
متن کاملUsage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India.
CONTACTS Many patients in this sample don’t achieve HbA1c-therapy-goals and many don’t test their blood glucose. Less than 1 in 5 patients performs the recommended test frequency. In IIT SMBG is needed to support insulin dose adjustments: only 1 in 50 tests enough. In CT patients the differences in HbA1c between testers and non-testers are largest. Lacking SMBG benefit in IIT treated patients m...
متن کاملSwitching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
OBJECTIVE To evaluate efficacy and safety of switching from twice-daily exenatide to once-daily liraglutide or of 40 weeks of continuous liraglutide therapy. RESEARCH DESIGN AND METHODS When added to oral antidiabetes drugs in a 26-week randomized trial (Liraglutide Effect and Action in Diabetes [LEAD]-6), liraglutide more effectively improved A1C, fasting plasma glucose, and the homeostasis ...
متن کاملOnce- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes.
OBJECTIVE To determine the efficacy of rosiglitazone compared with placebo in reducing hyperglycemia. RESEARCH DESIGN AND METHODS After a 4-week placebo run-in period, 959 patients were randomized to placebo or rosiglitazone (total daily dose 4 or 8 mg) for 26 weeks. The primary measure of efficacy was change in the HbA1c concentration. RESULTS Rosiglitazone produced dosage-dependent reduct...
متن کاملIntensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes
OBJECTIVE We aimed to evaluate the added value of intensive self-monitoring of blood glucose (SMBG), structured in timing and frequency, in noninsulin-treated patients with type 2 diabetes. RESEARCH DESIGN AND METHODS The 12-month, randomized, clinical trial enrolled 1,024 patients with noninsulin-treated type 2 diabetes (median baseline HbA1c, 7.3% [IQR, 6.9-7.8%]) at 39 diabetes clinics in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Diabetes Science and Technology
سال: 2015
ISSN: 1932-2968,1932-2968
DOI: 10.1177/1932296815608869